**Author details**

Nikhat Farhana\*, Mohammed Gulzar Ahmed, Mohammed Asif Iqbal, Nishmitha Gretta D'Souza, Sudhina Makuttan, Natasha Naval Aggarwal and Abdul Rahamanulla Yenepoya Pharmacy College and Research Center, Department of Pharmaceutical Chemistry, Yenepoya (Deemed to be University), Derlakatte, Mangaluru, Karnataka, India

\*Address all correspondence to: nik.nida13ada25@gmail.com

© 2022 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Reprofiling of Octogenarian Antiviral Agent: A New Avenue Venture to Discover Viral Infection DOI: http://dx.doi.org/10.5772/intechopen.102825*

## **References**

[1] Mani D, Wadhwani A, Krishnamurthy PT. Drug repurposing in antiviral research : A current scenario. Journal of Young Pharmacists. 2019;**11**(2):117-121

[2] Pizzorno A, Padey B, Terrier O, Rosa-calatrava M. Drug repurposing approaches for the treatment of influenza viral infection : Reviving old drugs to fight against a long-lived enemy. Journal of Young Pharmacists. 2019;**11**(2):117-121

[3] Mercorelli B, Palù G, Loregian A. Drug repurposing for viral infectious diseases : How far are we ? Trends in Microbiology. 2018;**26**(10):865-876. DOI: 10.1016/j.tim.2018.04.004

[4] Altay O, Mohammadi E, Lam S, Turkez H, Boren J, Nielsen J, et al. iScience ll current Status of COVID-19 therapies and drug repositioning applications. ISCIENCE. 2020;**23**(7): 101303. DOI: 10.1016/j.isci.2020.101303

[5] Sarkar A, Mandal K. Repurposing an antiviral drug against SARS-CoV-2 Main protease. Angew Chem Int Ed Engl. 2021 Oct 25;**60**(44):23492-23494

[6] Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, et al. Drug repurposing: Progress, challenges and recommendations. Nature Reviews Drug Discovery. 2018;**7**:234-238. DOI: 10.1038/ nrd.2018.168

[7] Sultana J, Crisafulli S, Gabbay F, Lynn E, Shakir S. Challenges for drug repurposing in the COVID-19 pandemic era. Front. Pharmacol. 2020;**11**(November):1-13

[8] Yang C, Peng T, Hsu H, Lee Y, Wu S, Lin W, et al. ScienceDirect repurposing old drugs as antiviral agents for coronaviruses. Biomedical J. 2020;**3**:3-9

[9] Parnham MJ, Erakovic V, Giamarellosbourboulis EJ, Perletti G, Verleden GM, Vos R. Pharmacology & Therapeutics Azithromycin : Mechanisms of action and their relevance for clinical applications. Pharmacology & Therapeutics. 2014;**143**(2):225-245. DOI: 10.1016/j.pharmthera.2014.03.003

[10] Rajkumar RP. Lithium as a candidate treatment for COVID-19: Promises and pitfalls. Drug Dev Res. 2020 Nov;**81**(7):782-785

[11] Cusinato J, Cau Y, Calvani AM, Mori M, Cusinato J, Cau Y, et al. Expert opinion on therapeutic patents repurposing drugs for the management of. Expert Opinion on Therapeutic Patents. 2021;**31**(4):295-308. DOI: 10.1080/13543776.2021.1861248

[12] Results ST. New England Journal. 2021;497-511

[13] Bauso LV, Imbesi C, Irene G, Cal G, Bitto A. New approaches and repurposed antiviral drugs for the treatment of the SARS-CoV-2 infection. Pharmaceuticals. 2021;**14**:1-19

[14] Swathi K, Nikitha B, Chandrakala B, Lakshmanadevi K, Malleswari M. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19. The COVID-19 resource centre is hosted on Elsevier Connect, the company ' s public news and information. 2020;(January)

[15] Trivedi J, Mohan M. Drug repurposing approaches to combating viral infections. J Clin Med. 2020 Nov 23;**9**(11):3777

[16] Moleculer structure which have Repurpusing potential. Molecules. 2021;**24**(1):29-31
